Market-Moving Exclusives Archives

2 minute read

EXCLUSIVE: Adial Pharmaceuticals Announces Publication In Journal Supporting the Potential Efficacy Of AD04 For Alcohol Use Disorder

June 20, 8:00 AM

Adial Pharmaceuticals publishes Phase 3 ONWARD study results in the European Journal of Internal Medicine. The study reveals AD04 significantly reduces heavy drinking days, with adverse events matching the placebo.

ADIL

2 minute read

EXCLUSIVE: Femasys At Inflection Point And Undervalued, Expects Growth Potential Following Roe v. Wade Overturn, CEO Says

By Vandana Singh

June 17, 3:22 AM

Femasys focuses on innovative women's healthcare solutions. Their FemBloc product, a non-surgical permanent birth control, is in late-stage development, aiming for a $20 billion market.

FEMY

3 minute read

EXCLUSIVE: ‘Prescription Erectile Dysfunction Market Could Triple If an ED Therapy Is Made Available OTC,’ Petros Pharma President Says

By Vandana Singh

June 17, 3:08 AM

Petros Pharmaceuticals specializes in men's health therapeutics. President Fady Boctor discusses the company's strategy to make key prescription medications. Petros is poised to expand within the $66.5 billion Rx-to-OTC market projected by 2033.

PTPI

2 minute read

Hedge Fund Settles At $2.25M With SEC For Exposed Short Seller Deal, 2 Cannabis Stocks Affected

By Rolando García

June 13, 3:29 PM

Discover how Anson Funds settled with the SEC for $2.25M over an undisclosed collaboration with short seller impacting cannabis stocks

IGC

2 minute read

EXCLUSIVE: Webuy Global Dives Into Longevity Market with NEONE, Aiming to Revitalize Health Supplement Space

By Anusuya Lahiri

June 13, 8:31 AM

Webuy Global Ltd announced its entry into nutraceutical and longevity markets with NEONE, a premium health supplement brand. NEONE offers high-quality, researched supplements for anti-aging and overall well-being.

WBUY

2 minute read

EXCLUSIVE: Vivani Medical’s Type 2 Diabetes Treatment NPM-119 Subdermal Implant’s NDA Gains FDA Clearance For Clinical Use

By Akanksha Bakshi

June 13, 7:01 AM

Vivani Medical cleared FDA for NPM-119 trial in type 2 diabetes. LIBERATE-1 will assess safety, tolerability, & pharmacokinetics. NPM-115 & NPM-139 also in development for weight management.

VANI

3 minute read

These States Could Go Fully Legal Soon & This Cannabis Company Could Win Big: A Top Stock Pick Trading Below Peers

By Nicolas Jose Rodriguez

June 12, 9:37 PM

Among the top 5 multi-state operators (MSOs) in the cannabis industry is Cresco Labs (OTC: CRLBF), with a significant presence in states like Ohio, Pennsylvania and Florida.

ACRHF

2 minute read

EXCLUSIVE: Horizon Fintex and Diamond Lake Minerals Ink $3.75M Deal to Enhance Upstream Trading Liquidity

By Anusuya Lahiri

June 11, 9:30 AM

GlobexUS and Diamond Lake have entered a $3.75M share exchange partnership to increase liquidity on the Upstream exchange and expand issuer opportunities.

DLMI

1 minute read

EXCLUSIVE: ImmunoPrecise Antibodies’ Subsidiary Releases Software With Customizable Interface For AI-Driven Drug Discovery

By Vandana Singh

June 10, 7:01 AM

ImmunoPrecise Antibodies launches BioStrand's LENSaiAPI software, enhancing AI-driven drug discovery and data integration for healthcare and pharmaceutical industries.

IPA

2 minute read

EXCLUSIVE: Adial Pharmaceuticals Starts Patient Dosing In Pharmacokinetics Study Of AD04 For Alcohol Use Disorder

By Vandana Singh

June 5, 8:00 AM

Adial Pharmaceuticals starts dosing in pharmacokinetics study of AD04 for Alcohol Use Disorder in heavy drinking patients. Topline results in early Q4 2024.

ADIL